This resolution affirms U.S. support for Israel's right to peace and security as well as its right to defend itself and its civilians against terror.
Audit the Pentagon Act of 2021 This bill requires the Department of Defense (DOD) to reduce spending for any department, agency, or other DOD element that DOD determines has not achieved an unqualified opinion on its full financial statements for the calendar year ending during that fiscal year. Specifically, the amount available to such department, agency, or element for the fiscal year when the determination is made must be 1% less than the amount otherwise authorized to be appropriated. Amounts unavailable to such department, agency, or element must be applied on a pro rata basis against each program, project, and activity. DOD must deposit such unavailable amounts in the general fund of the Department of the Treasury for purposes of deficit reduction.
Hemp Access and Consumer Safety Act This bill allows hemp and hemp-derived ingredients to be included in food and dietary supplements. Current law prohibits, with limited exceptions, the sale of food and dietary supplements that contain an ingredient that is an active ingredient in (1) an approved drug, or (2) a drug for which there have been substantial and publicly known clinical investigations. This bill exempts hemp and hemp-derived ingredients, such as hemp-derived cannabidiol, from this prohibition. The Food and Drug Administration may establish labeling and packaging requirements for such foods and dietary supplements.
Verified Innovative Testing in American Laboratories Act of 2021 or the VITAL Act of 2021 This bill expressly shifts the regulation of laboratory-developed testing procedures from the Food and Drug Administration (FDA) to the Centers for Medicare & Medicaid Services (CMS). Under current law, the FDA regulates the safety and effectiveness, as well as quality of design and manufacture, of laboratory-developed tests, while the CMS regulates clinical laboratories and testing processes. Historically, the FDA has exercised enforcement discretion and not enforced certain statutory and regulatory requirements with respect to these tests. The CMS must hold a public meeting to solicit recommendations to update existing regulations related to clinical laboratories, and the Department of Health and Human Services must report specified information to Congress, including an assessment of the availability and use of laboratory-developed testing procedures during the COVID-19 (i.e., coronavirus disease 2019) response.
This resolution designates the week of May 9-May 15, 2021, as National Police Week.
Limiting CDC to Disease Control Act This bill modifies and limits the authority of the Department of Health and Human Services (HHS) to issue regulations to control communicable diseases. Current law authorizes HHS to make and enforce regulations to prevent the introduction or spread of communicable diseases. In particular, current law provides that HHS may make and enforce regulations addressing (1) isolation and quarantine of infected individuals (subject to certain restrictions); and (2) inspection, fumigation, disinfection, sanitation, pest extermination, destruction of infected animals or articles, and other measures that the department determines may be necessary. HHS has delegated this authority to the Centers for Disease Control and Prevention (CDC). This bill eliminates the authority of the CDC to make and enforce regulations that provide for other measures it determines may be necessary to prevent the spread of communicable diseases, thereby limiting the scope of its regulations to the other specific purposes set out in current law.
Temporary Family Visitation Act This bill establishes a new nonimmigrant visa classification for an alien temporarily entering the United States to visit a relative who is a U.S. citizen or lawful permanent resident. The maximum period of stay for a family visitor visa shall be 90 days. An alien seeking such a visa must have health insurance for the duration of the stay. An alien who holds such a visa may not change to another nonimmigrant visa classification except in certain limited instances. If an alien has been approved for a family-based immigrant visa and is waiting for one to become available, the alien may obtain a family visitor visa if the alien meets the eligibility requirements.
This resolution designates the week beginning November 8, 2021, as National Pregnancy Center Week.
Legislative Performance Review Act of 2021 This bill limits the duration of authorizations of appropriations, requires programs with expired authorizations to be terminated, and establishes reporting requirements. The bill prohibits Congress from considering legislation that (1) authorizes appropriations for more than four years, or (2) authorizes the enactment of an unlimited amount of appropriations for any purpose. If Congress determines that an authorization for more than four years is necessary to accomplish the purposes of an authorization, it may waive the time limit by considering a waiver resolution using expedited legislative procedures. Congressional committees that report legislation authorizing appropriations must include in committee reports (1) an analysis, appraisal, and evaluation of existing programs for which appropriations are authorized; and (2) specified details regarding the purpose and need for new programs for which appropriations are authorized. Federal agencies must implement a plan to phase out certain programs with expired authorizations. The bill establishes points of order against legislation that provides appropriations that are either unauthorized or are pursuant to authorizations that violate the time limits established by this bill.
Long-Term Care Pharmacy Definition Act of 2021 This bill establishes a statutory definition for long-term care pharmacy under the Medicare prescription drug benefit. Currently, there is no statutory definition. Regulations from the Centers for Medicare & Medicaid Services (CMS) define a long-term care pharmacy as a pharmacy that is owned by or under contract with a long-term care facility to provide prescription drugs to the facility's residents. Additional requirements are set out in CMS guidance relating to the Medicare prescription drug benefit; pharmacies are also subject to regulations and guidance from other agencies (e.g., packaging requirements from the Food and Drug Administration). The bill defines a long-term care pharmacy as a state-licensed pharmacy that is able to provide enhanced pharmacy and clinical services to individuals who have certain comorbid and medically complex chronic conditions and who reside in skilled nursing facilities, nursing facilities, or any other applicable setting (as determined by the CMS). The term enhanced pharmacy and clinical services includes medication dispensed in special packaging, drug utilization review, and 24-7 availability of medication delivery and on-call pharmacists.
